CN1126046A - 降脂脱醇食用调料及其制备方法 - Google Patents
降脂脱醇食用调料及其制备方法 Download PDFInfo
- Publication number
- CN1126046A CN1126046A CN95115951A CN95115951A CN1126046A CN 1126046 A CN1126046 A CN 1126046A CN 95115951 A CN95115951 A CN 95115951A CN 95115951 A CN95115951 A CN 95115951A CN 1126046 A CN1126046 A CN 1126046A
- Authority
- CN
- China
- Prior art keywords
- fructus
- flavouring
- edible
- powder
- dealcoholization
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004369 blood Anatomy 0.000 title abstract description 9
- 239000008280 blood Substances 0.000 title abstract description 9
- 238000002360 preparation method Methods 0.000 title abstract description 5
- 235000011194 food seasoning agent Nutrition 0.000 title abstract 4
- 239000000843 powder Substances 0.000 claims abstract description 13
- 244000291564 Allium cepa Species 0.000 claims abstract description 6
- 239000007788 liquid Substances 0.000 claims description 17
- 239000000796 flavoring agent Substances 0.000 claims description 16
- 235000013355 food flavoring agent Nutrition 0.000 claims description 14
- 241000195474 Sargassum Species 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 11
- 230000002879 macerating effect Effects 0.000 claims description 7
- 230000001476 alcoholic effect Effects 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- 239000002304 perfume Substances 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 35
- 235000012000 cholesterol Nutrition 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 11
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract description 10
- 239000003814 drug Substances 0.000 abstract description 10
- 206010003210 Arteriosclerosis Diseases 0.000 abstract description 4
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract description 4
- 238000002156 mixing Methods 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 2
- 208000004930 Fatty Liver Diseases 0.000 abstract description 2
- 206010019708 Hepatic steatosis Diseases 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 abstract description 2
- 208000010706 fatty liver disease Diseases 0.000 abstract description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 abstract description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- 235000002732 Allium cepa var. cepa Nutrition 0.000 abstract 1
- 241001474374 Blennius Species 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 241001289529 Fallopia multiflora Species 0.000 abstract 1
- 235000017784 Mespilus germanica Nutrition 0.000 abstract 1
- 244000182216 Mimusops elengi Species 0.000 abstract 1
- 235000000560 Mimusops elengi Nutrition 0.000 abstract 1
- 235000007837 Vangueria infausta Nutrition 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 description 10
- 230000000968 intestinal effect Effects 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 5
- 238000010411 cooking Methods 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 239000003172 expectorant agent Substances 0.000 description 4
- 230000003419 expectorant effect Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 150000002367 halogens Chemical class 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 235000014347 soups Nutrition 0.000 description 3
- 150000003626 triacylglycerols Chemical class 0.000 description 3
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 2
- 239000004380 Cholic acid Substances 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 2
- 235000019416 cholic acid Nutrition 0.000 description 2
- 229960002471 cholic acid Drugs 0.000 description 2
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 235000013580 sausages Nutrition 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- -1 triterpenoid compound Chemical class 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- IZVFFXVYBHFIHY-SKCNUYALSA-N 5alpha-cholest-7-en-3beta-ol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)CCCC(C)C)CC[C@H]33)C)C3=CC[C@H]21 IZVFFXVYBHFIHY-SKCNUYALSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000217407 Margaritifera Species 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical class OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 208000001435 Thromboembolism Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000001906 cholesterol absorption Effects 0.000 description 1
- KNHUKKLJHYUCFP-UHFFFAOYSA-N clofibrate Chemical compound CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 KNHUKKLJHYUCFP-UHFFFAOYSA-N 0.000 description 1
- 229960001214 clofibrate Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000010224 hepatic metabolism Effects 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000000055 hyoplipidemic effect Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种降脂脱醇食用中药调料及其制备方法，以解决现有技术中西药有毒副作用、服用时间长、服用不便、不能多渠道联合用药的问题，由蒲黄、泽泻、山楂、海藻、洋葱、何首乌、枸杞按一定加工工艺制粉末并与调味料混匀制成。降脂脱醇疗效好，无毒副作用，服用方便，多渠道降胆固醇，可联合用药，对高血脂、动脉硬化引起的心血管疾病能起到有效的治疗和预防作用，对脂肪肝也有一定疗效。
Description
本发明属于一种含中草药的保健食品，尤其是涉及一种降脂脱醇的食用调料及其制备方法。
众多的研究资料表明，引起动脉粥样硬化的首要因素是高血脂症，中医认为，高血脂症与过食肥甘，嗜烟酒等因素有关，高血脂症、动脉硬化为“脉内痰浊凝结”所致，“痰浊粘滞于血，留而不去，痰血互结”形成多余血脂。降脂西药服用时间长，都有毒、副作用。世界卫生组织曾于60年代用安妥明对3万名30-50岁的男性进行人群性防治，历时五年，后因副作用大而末予推广；中医采用滋肝养肾、助脾胃、消痰湿化瘀浊的治疗方法，1992年12月23日公告，公告号为1067179的中国发明专利公开了一种降血脂药，它由何首乌等8味中药组方经过一定的加工工艺制成口服液、冲剂等；1993年3月31日公告，公告号为1070340的中国发明专利公开了一种降压、降脂药及其配制方法，采用黄芩、蚤休、生大黄、桅子、珍珠母、五味子等中药经过干燥、混合配制而成的，这些中医汤药、丸剂、口服液等，有很多缺点，一是长期服用病人很痛苦，二是服用不方便，三是不能多渠道联合用药，药量受限制，疗效不明显。
本发明的目的在于提供一种降脂脱醇疗效好、服用方便、无毒副作用的降脂脱醇食用调料其制备方法，对高血脂、动脉硬化引起的心脑血管疾病能起到有效的治疗和预防作用，对脂肪肝也有一定疗效。
为达到上述目的，本发明采用的技术方案是：降脂脱醇食用调料是由以下重量配比的原料制成的粉剂：
蒲黄5-10份 泽泻5-10份 山楂7-13份
海藻5-10份 洋葱15-30份 何首乌5-10份
枸杞5-10份 调味料30-50份
本发明的降脂脱醇食用调料的配方的优选重量配比范围是：
蒲黄6-10份 泽泻5-8份 山楂7-10份
海藻6-10份 洋葱20-30份 何首乌5-8份
枸杞5-8份 调味料30-45份
蒲黄用50-60％、泽泻用55-65％、海藻用35-50％、何首乌用35-50％的乙醇溶液分别温浸，回收液体，山楂、枸杞用水温浸，回收液体，将上述液体按顺序粗滤、助滤、脱色、除菌、精纯、浓缩、干燥，制取粉末，与洋葱蒸馏分离出的葱油和调味料混匀成粉剂。
调味料是指大茴、小茴、肉桂、花椒、胡椒、陈皮、砂仁、山奈、干姜等的一种或几种制成的粉末香料。
本发明降脂脱醇食用调料的食用方法为：卤煮料每人餐加该食用调料15克，馅料每人餐加10克，汤料每人餐加5克，烹调料每人餐加10克，一日三次，添加剂可适量加入香肠、馒头中。
本发明降脂脱醇食用调料的优点是：(1)护肝利胆，纠正肝脏代谢紊乱，促进胆固醇排泄。泽泻富含不饱和脂肪酸，有促进胆固醇向胆汁酸转化作用；枸杞可预防如烟酸类、苯氧乙酸衍生物类等对肝脏的毒性作用。(2)抑制外源性脂类的吸收，阻止肠道再吸收胆酸和内源性胆固醇，加快肠道排泄胆固醇。蒲黄、海藻含谷甾醇，能与胆固醇竞争脂化酶，减少胆固醇在肠道的脂化和吸收，海藻含的褐藻酸钠，可促使粪便排泄胆固醇；何首乌能与胆固醇结合，增进肠胃蠕动，减少胆固醇吸收；泽泻含三萜类化合物，可抑制小肠脂化胆固醇的能力；蒲黄能阻止肠道再吸收胆酸和内源性胆固醇，加快肠道排出。这几种药物互相配合，从不同渠道抑制肠壁吸收胆固醇并促进其排泄，(3)从肝内抑制胆固醇的合成。蒲黄能抑制肝脏合成胆固醇，并促进其代谢；泽泻含三萜类化合物，可减少胆固醇合成原料-乙酰辅酶A的生成量，使胆固醇合成率下降。(4)促进血液中脂类的运输和清除，防治动脉粥样硬化。泽泻对抗ADP和胶源引起的血小板聚集，缓和而较为持久地松驰动脉平滑肌，降低血压；蒲黄可抗纤维蛋白损伤，保护血管内皮细胞，激活巨噬细胞吞噬动脉壁的脂质；何首乌可减少血栓形成，减少脂质斑块形成；枸杞可抗应激，抑制血小板凝聚，使血栓溶解，硬化斑块消退。(5)无毒副作用。山楂对肠胃具有消炎防腐、增加免疫作用。(6)能制成各种调料，如卤煮料、馅料、汤料、烹调料，不加调味料可制成添加剂，与食物相依，食用方便，无苦异味，可日常服用，以解除长期服药之苦。
下面结合病例和实施例本发明的降脂脱醇食用调料作进一步详细的说明。
病例1、王××，男，42岁，河南省平顶山市高压开关厂职工，患糖尿病、高血脂症，每午、晚两餐食用降脂脱醇食用调料45天，血清总脂由975mg/bl，降到675mg/bl，血清胆固醇由365mg/bl降到215mg/bl，血清甘油三脂由210mg/b1降到126mg/bl，愈后末再复发。
病例1、李××，男，51岁，平顶山市百货公司司机，1991年4月前来就诊。查患高血压、动脉硬化、高血脂症，病人患病12年，服用中、西药疗效不明显，且有肠胃反应，每日午、晚两餐食用降脂脱醇食用调料45天，血清总脂由935mg/b1降至765mg/bl，血清胆固醇由295mg/bl降至236mg/bl，血清甘油三酯由193mg/bl降至117mg/bl，痊愈后末再复发。
病例3、韩××，男，43岁，平顶山市百货公司司机，1991年5月由李××引见前来就诊。查患高血压、高血脂症，每日午、晚两餐食用降酯脱醇食用调料一个疗程45天，血清胆固醇由396mg/bl降至195mg/bl，血清总脂由983mg/bl降至732mg/bl，血清甘油三脂由142mg/bl降至112mg/bl，服后症状解除，效果良好。
病例4、赵××，男，42岁，平顶山市建安公司职工，1991年5月前来就诊。查患心肌梗塞、高血脂症，每日午、晚两餐用降酯脱醇调料炒菜，连用45天，血清总脂由921mg/bl降至625mg/bl.，血清胆固醇由405mg/bl降至210mg/bl，血清甘油三酯由193mg/bl降至110mg/bl，用后效果良好，末有复发。
病例5、韩××，女，47岁，平顶山矿务局三矿职工，患冠心病、高血脂症6年，服用中、西药均无效，于1991年7月前来就诊，按每日午、晚两餐加降酯脱醇调料，连用45天，血清总脂由1015mg/bl降至765mg/bl，血清胆固醇由423mg/bl降至243mg/bl，血清甘油三酯由230mg/bl降至125mg/bl，用后症状解除，末再复发。
实施例1，取除杂粉碎的蒲黄10克用60％、泽写10克用65％、海藻10克用50％、何首乌10克用50％的乙醇溶液温浸，回收液体，洋葱30克蒸馏取葱油，山楂13克、枸杞10克粉碎后用水湿浸，回收液体，然后将上述药液分别用加压叶滤机粗滤，加活性炭助滤脱色，除菌、精纯、浓缩、提纯、干燥，制取粉末，与调味料50克混融制成卤煮料或馅料、烹调料。
实施例2、取除杂粉碎的蒲黄8克用55％、泽泻7.5克用60％、海藻7.5克用40％、何首乌7.5克用40％的乙醇溶液湿浸，回收液体，洋葱25克蒸馏取葱油，山楂10克、枸杞7.5克粉碎后用水温浸，回收液体，然后将上述药液分别用加压叶滤机粗滤，加活性炭助滤脱色，除菌、精纯、浓缩、提纯、干燥，制取粉末，与调味料40克混融成汤料。
实施例3、取除杂粉碎的蒲黄5克用50％、泽泻5克用55％、海藻5克用35％、何首乌5克用35％的乙醇溶液湿浸，回收液体，洋葱15克蒸馏取葱油，山楂7克、枸杞5克粉碎后用水温浸，回收液体，然后将上述药液分别用加压叶滤机粗滤，加活性炭助滤脱色，除菌、精纯、浓缩、提纯、干燥，制取粉末作添加入馒头香肠等食品中。
Claims (4)
1、降脂脱醇食用调料，其特征在于它是由以下重量配比的原料制成的粉剂：
蒲黄5-10份，泽泻5-10份，山楂7-13份，海藻5-10份，洋葱15-30份，何首乌5-10份，枸杞5-10份，调味料30-50份。
2、根据权利要求1所述的降脂脱醇食用调料，其中各原料的重量配比是：
蒲黄6-10份 泽泻5-8份 山楂7-10份
海藻6-10份 洋葱20-30份 何首乌5-8份
枸杞5-10份 调味料30-45份
3、根据权利要求1或2所述的降脂脱醇食用调料，其特征在于：调味料是大茴、小茴、肉桂、花椒、胡椒、陈皮、砂仁、山奈、干姜等的一种或几种制成的粉末香料。
4、制备权利要求1所述的降脂脱醇食用调料的方法，其特征在于：蒲黄用50-60％、泽泻用55-65％、海藻用35-50％、何首乌用35-50％的乙醇溶液分别温浸，回收液体，山楂，枸杞用水温浸，回收液体，将上述液体按顺序粗滤、助滤、脱色、除菌、精纯、浓缩、干燥、制取粉末，与洋葱蒸馏分离出的葱油和调味料混匀成粉剂。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN95115951A CN1057899C (zh) | 1994-11-11 | 1995-10-16 | 降脂脱醇食用调料及其制备方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN94113639A CN1109777A (zh) | 1994-11-11 | 1994-11-11 | 降脂脱醇食用调料 |
| CN94113639.6 | 1994-11-11 | ||
| CN95115951A CN1057899C (zh) | 1994-11-11 | 1995-10-16 | 降脂脱醇食用调料及其制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1126046A true CN1126046A (zh) | 1996-07-10 |
| CN1057899C CN1057899C (zh) | 2000-11-01 |
Family
ID=25743484
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN95115951A Expired - Fee Related CN1057899C (zh) | 1994-11-11 | 1995-10-16 | 降脂脱醇食用调料及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1057899C (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1085066C (zh) * | 1998-03-17 | 2002-05-22 | 蓝进 | 降脂食品添加剂 |
| CN101731556A (zh) * | 2008-11-13 | 2010-06-16 | 龟甲万(新加坡)研发实验室私人有限公司 | 一种食品用的液态强化调味品及其制备方法 |
| CN103230033A (zh) * | 2013-03-29 | 2013-08-07 | 蚌埠市丰牧牛羊肉制品有限责任公司 | 一种虾仁香肠及其制作方法 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103564390A (zh) * | 2013-09-26 | 2014-02-12 | 鲁杨 | 一种烹调烧烤用葱粉及其制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1103266A (zh) * | 1993-12-03 | 1995-06-07 | 程孝 | 药膳调料及其制作方法 |
-
1995
- 1995-10-16 CN CN95115951A patent/CN1057899C/zh not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1085066C (zh) * | 1998-03-17 | 2002-05-22 | 蓝进 | 降脂食品添加剂 |
| CN101731556A (zh) * | 2008-11-13 | 2010-06-16 | 龟甲万(新加坡)研发实验室私人有限公司 | 一种食品用的液态强化调味品及其制备方法 |
| CN103230033A (zh) * | 2013-03-29 | 2013-08-07 | 蚌埠市丰牧牛羊肉制品有限责任公司 | 一种虾仁香肠及其制作方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1057899C (zh) | 2000-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103861070B (zh) | 一种预防血管硬化的保健品 | |
| CN103622030A (zh) | 一种便秘食疗组合物及制备方法 | |
| CN102652801A (zh) | 一种降血糖及防治糖尿病并发症的中草药袋泡茶 | |
| CN105727205A (zh) | 一种具有减肥和降血脂作用的组合物及其制备方法与应用 | |
| CN103610850A (zh) | 一种治疗高脂血症的药物 | |
| CN110841026A (zh) | 一种具有健脾祛湿减肥的复方制剂及其制备方法 | |
| CN1057899C (zh) | 降脂脱醇食用调料及其制备方法 | |
| CN104225503A (zh) | 一种玛咖复方中药制剂及其制备方法 | |
| CN103893389A (zh) | 一种降血压的中药茶饮 | |
| WO2023100764A1 (ja) | 気虚及び／又は血虚に関連する症状の予防、改善又は緩和のための組成物 | |
| CN1109777A (zh) | 降脂脱醇食用调料 | |
| CN110090253B (zh) | 一种天然植物降脂组合物及其制备方法 | |
| CN106035749A (zh) | 一种保健果味棉籽调和油 | |
| CN110959721A (zh) | 一种食凉茶固体饮料 | |
| CN115671175B (zh) | 一种用于降血脂的香榧子药物组合物及其制备方法 | |
| CN1650916A (zh) | 一种治疗脘腹胀满疼痛的中药制剂 | |
| CN106309795A (zh) | 一种养生减肥中药丸及制备方法 | |
| KR102217303B1 (ko) | 간질환 치료 및 간기능 개선용 약학 조성물 | |
| CN1762440A (zh) | 一种防治心脑血管疾病的药物 | |
| CN103656468B (zh) | 一种丹参脂肝康制剂及其制备方法 | |
| CN117244028A (zh) | 一种用于酒精性肝病的组合物及其制备方法和用途 | |
| WO2003026569A2 (en) | Composition and method for the treatment of hypercholesterolemia and hyperlipidemia in mammals | |
| CN104147245B (zh) | 一种猪毛菜组合物、其制备方法及其在制备减肥降脂药物中的应用 | |
| CN103495073A (zh) | 一种解决碳水化合物不耐症、安全减肥的组配方法 | |
| CN114533835A (zh) | 一种具有芳香、祛风利湿功效的药物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |